Results 211 to 220 of about 864,749 (292)

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectives. [PDF]

Hum Vaccin Immunother
Morandi E, Della Peruta M, Mancini F, Rossi O, Loomis RJ, Iturriza-Gómara M.   +5 more
europepmc   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

Outer membrane vesicles from <i>Fusobacterium necrophorum</i> elicit protective immunity in mice and robust immune responses in sheep. [PDF]

Virulence
Zhao P, Jiang J, Yang N, Liu R, Jiang K, Bi L, He X, Guo D.   +7 more
europepmc   +1 more source

From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy

BMEMat, EarlyView.
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen, Weichen Zhang, Gaoli Niu, Li Wang, Ruiyan Li, Yueyue Fan, Feixue Lu, Lingling Xu, Xiaoyuan Ji, Yong Kang   +9 more
wiley   +1 more source

Cellular and Humoral Immune Responses in Anti-N Seropositive and Seronegative Vaccinated Participants: Insights from the Bialystok PLUS Study. [PDF]

Vaccines (Basel)
Trojan G, Moniuszko-Malinowska A, Adamczuk J, Citko-Rojewska A, Alimowski M, Czupryna P, Sequeira K, Nguyen H, Dunaj-Małyszko J, Sowa P, Dubatówka M, Łapińska M, Sołomacha S, Kazberuk M, Chlabicz M, Kiszkiel Ł, Szczerbiński Ł, Laskowski PP, Kamiński KA.   +18 more
europepmc   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Multi-epitope mRNA vaccine and protein vaccine protect mice against Toxoplasma gondii. [PDF]

Parasit Vectors
Cui Y, Qu H, Zhou C, Liang Z, Han B, Zhou H, Cong H.   +6 more
europepmc   +1 more source